<DOC>
	<DOCNO>NCT01844245</DOCNO>
	<brief_summary>Only small proportion patient cholangiocarcinoma ampullary carcinoma suitable surgical resection . The endoscopic percutaneous transhepatic biliary drainage accept approach relief jaundice malignant biliary obstruction . But restoration bile flow improvement survival cancer patient . By use endobiliary radiofrequency energy destruct tumorous tissue may delay tumour growth , might improve survival patient . The feasibility safety technique use HabibTM EndoHBP probe evident . The aim randomise , control , multicentre study evaluate whether endobiliary radiofrequency ablation ( RFA ) improve median survival patient unresectable biliary malignancy .</brief_summary>
	<brief_title>Endobiliary RFA Unresectable Malignant Biliary Strictures</brief_title>
	<detailed_description>RFA well establish method treatment solid tumor , like liver cancer , lung cancer , etc . Recently , endoscopically applicable radiofrequency probe , HabibTM EndoHBP catheter , approve clinical use . It use bipolar electrical energy tissue coagulation easily apply endoscopic retrograde cholangiopancreatography ( ERCP ) . Endobiliary radiofrequency destruct tumor tissue potential benefit control tumour growth . Several cohort study publish feasibility safety technique prove . The aim study conduct randomise , control , multicentre clinical trial compare effect endobiliary RFA plus biliary stenting biliary stenting patient unresectable cholangiocarcinoma ampullary carcinoma . The objective - To evaluate whether endobiliary RFA prior biliary stenting improve patient ' survival compare stenting therapy . - To assess impact RFA stent 's patency .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<criteria>Either gender great equal 18 year age . Cholangiocarcinoma ampullary cancer unsuitable surgical resection staging , comorbidities patient wish . Criteria unresectability base 1 ) metastatic disease 2 ) locally advanced . Biliary obstruction , Bilirubin &gt; 40umol/L diagnosis Subjects capable give informed consent Life expectancy least 3 month Histologically ( prefer ) radiologically confirm cholangiocarcinoma ampullary cancer Cardiac Pacemaker Patient unstable endoscopy Inability give inform consent Coagulopathy ( INR &gt; 2.0 PTT &gt; 100 sec platelet count &lt; 50,000 ) Performance status ECOG â‰¥3 ( confine bed / chair &gt; 50 % waking hour ) Active suppurative cholangitis Complex stenoses eligible trial Patients without access duodenum ampulla candidate ERCP stenting Malignant ascites Presence main portal vein thrombosis Prior stent placement Prior Billroth II rouxen Y reconstruction Inability insert guide wire across malignant stricture Pregnancy Presence malignancy Life expectancy &lt; 3months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Cholangiocarcinoma</keyword>
	<keyword>Ampullary carcinoma</keyword>
	<keyword>Endoscopic retrograde cholangiopancreatography</keyword>
	<keyword>Radiofrequency ablation</keyword>
</DOC>